The Employment of Leukotriene Antagonists in Cutaneous Diseases Belonging to Allergological FieldNETTIS, Eustachio; D'ERASMO, Maddalena; DI LEO, Elisabetta et al.Mediators of inflammation. 2010, Vol 2010, Num 2, issn 0962-9351, 628171.1-628171.6Article

Cysteinyl-leukotriene receptor antagonist, bronchoconstriction, and airway hyperreactivityAALBERS, R; DE MONCHY, J. G. R.Lancet (British edition). 1991, Vol 338, Num 8764, issn 0140-6736, p. 445Article

Short-term effects of montelukast in stable patients with moderate to severe COPDCELIK, Pinar; SAKAR, Aysin; HAVLUCU, Yavuz et al.Respiratory medicine. 2005, Vol 99, Num 4, pp 444-450, issn 0954-6111, 7 p.Article

Asthma: A brief overviewSHEPHERD, Jinna M; DUDDLESTON, David N; HICKS, G. Swink et al.The American journal of the medical sciences. 2002, Vol 324, Num 4, pp 174-179, issn 0002-9629, 6 p.Article

WF11605, an antagonist of leukotriene B₄ produced by a fungus. II : Structure determinationSHIGEMATSU, N; TSUJII, E; KAYAKIRI, N et al.Journal of antibiotics (Tokyo. 1968). 1992, Vol 45, Num 5, pp 704-708, issn 0021-8820Article

Impact of inhaled corticosteroids and leukotriene receptor antagonists on airway remodelingHOSHINO, Makoto.Clinical reviews in allergy and immunology. 2004, Vol 27, Num 1, pp 59-64, issn 1080-0549, 6 p.Article

Chromatographic analysis of residual acetate in bulk drugsSEE, M. M; THOMPSON, R; GRINBERG, N et al.Journal of liquid chromatography. 1995, Vol 18, Num 1, pp 137-154, issn 0148-3919Article

Urinary LTE₄ excretion in antigen-provoked asthmatic patients treated with the inhaled LTD₄ antagonists, L-648,051RASMUSSEN, J. B; ERIKSSON, L.-O; TAGARI, P et al.Allergy, European journal of allergy and clinical immunology. 1992, Vol 47, Num 6, pp 599-603Article

Neuropathy in eosinophilic granulomatosis with polyangiitis: a comparison study of 24 cases with or without prior leukotriene antagonist exposureGIUSTI DEL GIARDINO, L; CAVALLARO, T; ANZOLA, G. P et al.European annals of allergy and clinical immunology. 2014, Vol 46, Num 6, pp 201-209, issn 1764-1489, 9 p.Article

Peptide leukotrienes : current status of researchSHAW, A; KRELL, R. D.Journal of medicinal chemistry (Print). 1991, Vol 34, Num 4, pp 1235-1242, issn 0022-2623, 8 p.Article

The Role of Decongestants, Cromolyn, Guafenesin, Saline Washes, Capsaicin, Leukotriene Antagonists, and Other Treatments on RhinitisKUSHNIR, Nataliya M.Immunology and allergy clinics of North America. 2011, Vol 31, Num 3, issn 0889-8561, vii, 601-617 [18 p.]Article

Therapeutic modulation of allergic airways disease with leukotriene receptor antagonistsCURRIE, G. P; SRIVASTAVA, P; DEMPSEY, O. J et al.QJM (Oxford. 1994. Print). 2005, Vol 98, Num 3, pp 171-182, issn 1460-2725, 12 p.Article

Identification of the human cytochrome P450s responsible for the in vitro metabolism of a leukotriene B4 receptor antagonist, CP-195,543KHOJASTEH-BAKHT, S. C; ROSSULEK, M. I; FOUDA, H. G et al.Xenobiotica (London. Print). 2003, Vol 33, Num 12, pp 1201-1210, issn 0049-8254, 10 p.Article

Rate of Suicide in Patients Taking MontelukastJICK, Hershel; WILCOX HAGBERG, Katrina; EGGER, Pascal et al.Pharmacotherapy. 2009, Vol 29, Num 2, pp 165-166, issn 0277-0008, 2 p.Article

Churg-Strauss syndrome and leukotriene antagonist use : a respiratory perspectiveNATHANI, N; LITTLE, M. A; KUNST, H et al.Thorax. 2008, Vol 63, Num 10, pp 883-888, issn 0040-6376, 6 p.Article

Montelukast does not protect against hyperoxia-induced inhibition of alveolarization in newborn ratsJOUVENCEL, Philippe; FAYON, Michael; CHOUKROUN, Marie-Luce et al.Pediatric pulmonology. 2003, Vol 35, Num 6, pp 446-451, issn 8755-6863, 6 p.Article

Leukotrienantagonisten bei atopischen Erkrankungen und Akne = Leukotriene antagonists in atopic diseases and acneZOUBOULIS, Ch. C.Aktuelle Dermatologie. 2003, Vol 29, Num 10, pp 419-425, issn 0340-2541, 7 p.Article

Montelukast in the treatment of children with moderate-to-severe atopic dermatitis : A pilot studyYUK SAU PEI, Ann; HIN LEE CHAN, Henry; TING FAN LEUNG et al.Pediatric allergy and immunology. 2001, Vol 12, Num 3, pp 154-158, issn 0905-6157Article

Overview of childhood asthma: focus on montelukast. A seminar-in-printSHAPIRO, Gail G.Drugs (Basel). 2000, Vol 59, issn 0012-6667, 50 p., SUP1Serial Issue

Leukotriene receptor antagonists and asthmaTHOMPSON, P. J.Current therapeutics. 1999, Vol 40, Num 4, pp 35-41, issn 0311-905X, 6 p.Article

Nouvelles perspectives thérapeutiques anti-inflammatoires dans l'asthme = Anti-inflammatory drug in asthmeDESMARQUEST, P; CLEMENT, A.Concours médical (Paris). 1999, Vol 121, Num 14, pp 1075-1078, issn 0010-5309Article

Montelukast for chronic asthma in 6- to 14-year-old children: A randomized, double-blind trialKNORR, B; MATZ, J; BERNSTEIN, J. A et al.JAMA, the journal of the American Medical Association. 1998, Vol 279, Num 15, pp 1181-1186, issn 0098-7484Article

Montelukast once daily inhibits exercise-induced bronchoconstriction in 6- to 14-year-old children with asthmaKEMP, J. P; DOCKHORN, R. J; SHAPIRO, G. G et al.The Journal of pediatrics. 1998, Vol 133, Num 3, pp 424-428, issn 0022-3476Article

Anti-leukotriene therapy in asthmaDIAMANT, Z; BEL, E. H; DEKHUIJZEN, P. N. R et al.Netherlands journal of medicine. 1998, Vol 53, Num 4, pp 176-189, issn 0300-2977Article

Tubulointerstitial nephritis induced by the leukotriene receptor antagonist pranlukastSCHURMAN, S. J; ALDERMAN, J. M; MASSANARI, M et al.Chest. 1998, Vol 114, Num 4, pp 1220-1223, issn 0012-3692Article